1 / 4

Global Intravenous Iron Drug Market Trends, Size, Competitive Analysis and Forec

The global intravenous iron drug market is projected to grow at a CAGR of around 7% during the forecast period. Iron plays a vital role in the human body; it transfers oxygen via blood throughout the body.

Meenoo
Télécharger la présentation

Global Intravenous Iron Drug Market Trends, Size, Competitive Analysis and Forec

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research Global Intravenous Iron Drug Market, Size, Share, Analysis Report & Forecast to 2026 To Market: https://www.omrglobal.com/request-sample/intravenous-iron-drug-market Request a Sample of our Report on Global Intravenous Iron Drug Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

  2. The global intravenous iron drug market is projected to grow at a CAGR of around 7% during the forecast period. Iron plays an important role in the transportation of oxygen throughout the body. The key factors that drive the growth of the global intravenous iron drug industry include the increased prevalence of various disorders such as failures, nephrology, gynecology, gastroenterology, and others. One of the applications of the intravenous iron drug is in the treatment of irritable bowel syndrome (IBS). (Get 15% Discount on Buying this Report) A full Report of Global Intravenous Iron Drug Market is Available at: https://www.omrglobal.com/industry-reports/intravenous-iron-drug-market IBS is an intestinal disorder that causes abdominal pain, diarrhea, bloating, and constipation. According to the American Society of Gastrointestinal Endoscopy (ASGE), around 7-21% of the general population is suffering from IBS across the globe. There are few medications available in the market that offer relief to the disorder. As many as one-third of all patients with inflammatory bowel disease (IBD) have iron- deficiency anemia (IDA). Therefore, the high prevalence of IBD or IBS may create an opportunity for the growth of the global intravenous iron drug market. Further, the availability of various treatment methods is also the factor influencing the market growth. Other factors affecting the growth of the market include various contributions by government and private organizations for the development and R&D activities. The collaboration among research institutes and hospitals is also contributing to the market. The healthcare expenditure in countries such as the US, India, and China is growing significantly with the increasing interest from both the private and public sectors. These economies are amongst the fastest developing countries in the adoption and implementation of new technologies across the globe, which, thereby provide a wide scope for the growth of the market. Further, the presence of the key players that provides suitable and proper services and drugs also drives the growth of the market. Players such as Allergan PLC., American Regent, Inc., Daiichi Sankyo Co., Ltd., Pharmacosmos Group, Rockwell Medical Technologies, Inc., Sanofi SA, Keryx Biopharmaceuticals Inc., and Vifor Pharma Ltd. are significantly contributing to the growth of the global intravenous iron drug market. To Request a Sample of our Report Market: https://www.omrglobal.com/request-sample/intravenous-iron-drug-market on Global Intravenous Iron Drug Global Intravenous Iron Drug Market – Segmentation By Product •Ferric Carboxymaltose •Iron Sucrose •Iron Dextran •Others (Ferric Gluconate) By Application •Oncology •Chronic Kidney Diseases •Inflammatory Bowel Diseases •Others Global Intravenous Iron Drug Market – Segmentation by Region North America •United States

  3. •Canada Europe •UK •Germany •Spain •France •Italy •Rest of Europe Asia-Pacific •India •China •Japan •Rest of APAC Rest of The World •Middle East & Africa •Latin America Company Profiles •Akebia Therapeutics, Inc. •Allergan PLC •AMAG Pharmaceuticals, Inc. •American Regent, Inc. •AstraZeneca PLC •Bristol-Myers Squibb Co. •Daiichi Sankyo Co., Ltd. •FibroGen •Pieris Pharmaceuticals Inc. •Pharmacosmos Group •Rockwell Medical, Inc. •Sanofi SA •Shield Therapeutics Plc •Vifor Pharma Management Ltd. Reasons for Buying from us – 1. We cover more than 15 major industries, further segmented into more than 90 sectors. 2. More than 120 countries are for analysis. 3. Over 100+ paid data sources mined for investigation. 4. Our expert research analysts answer all your questions before and after purchasing your report.

  4. For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report- customization/intravenous-iron-drug-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research- based services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 7803040404

More Related